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  37 
Abstract 38 
 39 
Appropriate human trophoblast lineage specification and differentiation is crucial for the 40 
establishment of normal placentation and maintenance of pregnancy. However, due to the lack of 41 
proper modeling systems, the molecular mechanisms of these processes are still largely 42 
unknown. Much of the early studies in this area have been based on animal models and tumor-43 
derived trophoblast cell lines, both of which are suboptimal for modeling this unique human 44 
organ. Recent advances in regenerative and stem cell biology methods have led to development 45 
of novel in vitro model systems for studying human trophoblast. These include derivation of 46 
human embryonic and induced pluripotent stem cells and establishment of methods for the 47 
differentiation of these cells into trophoblast, as well as the more recent derivation of human 48 
trophoblast stem cells.  In addition, advances in culture conditions, from traditional two-49 
dimensional monolayer culture to three-dimensional culturing systems, have led to development 50 
of trophoblast organoid and placenta-on-a-chip model, enabling us to study human trophoblast 51 
function in context of more physiologically accurate environment. In this review, we will discuss 52 
these various model systems, with a focus on human trophoblast, and their ability to help 53 
elucidate the key mechanisms underlying placental development and function.  54 
 55 
 56 
  57 
Introduction 58 
Trophoblast (derived from the Greek word “tropho,” meaning to feed) is the epithelial cell in the 59 
placenta, a transient organ which plays a pivotal role in fetal growth and development during 60 
pregnancy. Understanding trophoblast differentiation is crucial for unraveling placental 61 
development and function across gestation, as well as placenta-based complications of 62 
pregnancy. Abnormal trophoblast differentiation has been associated with numerous pregnancy 63 
complications, including recurrent miscarriage, preeclampsia, and fetal growth restriction 64 
(Jauniaux et al. 2006; Norwitz ER 2006; Romero et al. 2011).  65 
Placental epithelium is derived from the trophectoderm—the outer layer of the pre-66 
implantation blastocyst-stage embryo, which gives rise to three distinct trophoblast subtypes. 67 
Cytotrophoblast (CTB) are considered proliferative stem/progenitor cells.  Within floating villi, 68 
CTBs undergo cell-cell fusion to form a multinucleated syncytiotrophoblast (STB), which 69 
secretes human chorionic gonadotropin (hCG), placental lactogen (hPL, also called chorionic 70 
somatomammotropin hormone or CSH) and pregnancy-specific glycoproteins (PSGs), and is 71 
involved in nutrient/gas exchange.  Within trophoblast cell columns of anchoring villi, CTBs 72 
differentiate into extravillous trophoblast (EVT), a highly motile cell type which invades the 73 
maternal uterine wall to remodel spiral arteries and establish blood supply to the feto-placental 74 
unit (Bischof and Finger 2005; James et al. 2012).  75 
As the most evolutionarily divergent organ, the human placenta, and specifically human 76 
trophoblast, have been difficult to study, mostly due to the lack of reproducible and widely-77 
available model systems which accurately represent these cells in vivo. However, a combination 78 
of recent advances in regenerative medicine has greatly expanded our ability to model this 79 
important cell type at the maternal-fetal interface.  These include the ability to reprogram a wide 80 
range of somatic cell types into induced pluripotent stem cells (iPSCs) (Takahashi et al. 2007), 81 
which can subsequently be differentiated into trophoblast (Amita et al. 2013; Horii et al. 2016), 82 
and establishment of culture conditions for growth and expansion of both human trophoblast 83 
stem cells (hTSC) (Okae et al. 2018) and self-replicating human placental organoids (Haider et 84 
al. 2018; Turco et al. 2018). Most recently, several groups have also brought together various 85 
cell types to develop placenta-on-a-chip models (Blundell et al. 2016; Arumugasaamy et al. 86 
2018; Nishiguchi et al. 2019).  In this review, we will describe these recent advances, detailing 87 
the advantages and limitations of each model system, and placing them in the larger context of 88 
both the past and future of this important area of reproduction. 89 
 90 
Human trophoblast lineage specification and early placental development 91 
 Much of what we know about TE establishment comes from studies in mice, which have 92 
identified a primary role for the Hippo signaling pathway in this process (Nishioka et al. 2009). 93 
Specifically, this pathway is turned off in the outer (TE) cells of late-stage morula, leading to 94 
formation of a Tead4-Yap1 complex, which subsequently induces Cdx2, a master switch of TE 95 
cell fate (Strumpf et al. 2005).  Downstream of Cdx2, other transcription factors are induced, 96 
including Eomes and Elf5, which help to maintain proliferative mouse trophoblast stem cells 97 
(mTSC) within the extraembryonic ectoderm layer of the early post-implantation embryo (Russ 98 
et al. 2000; Donnison et al. 2005; Senner and Hemberger, 2010). Gata2 and Gata3 transcription 99 
factors have also been found to play significant, albeit redundant, roles in establishment of TE 100 
(Home et al. 2017).  101 
Little is known about the mechanism(s) behind specification of trophectoderm (TE) in the 102 
human embryo.  Recent studies, using a combination of immunostaining and single-cell 103 
RNAseq, have identified significant differences in marker expression between mouse and human 104 
pre-implantation embryos, including absence of ELF5 and EOMES in human TE (Niakan and 105 
Eggan, 2013; Yan et al. 2013; Blakeley et al. 2015; Petropoulos et al. 2016).  In addition, several 106 
lines of evidence, including a prolonged period during which the pluripotency marker 107 
POU5F1/OCT4 and the TE marker CDX2 are co-expressed in the TE layer, suggest that human 108 
TE is not specified until at least the late blastocyst stage (Niakan et al. 2012; Niakan and Eggan 109 
2013). In fact, TE cells, taken from a day 5 human blastocyst and repositioned into the center of 110 
the same embryo, did not sort back to their original position and induced expression of NANOG, 111 
an epiblast marker (De Paepe et al. 2013). Furthermore, while Pou5F1/Oct4 is not involved in 112 
TE specification in mouse, the targeted knockout of its ortholog in the human blastocyst was 113 
found to affect gene expression in both the epiblast and TE compartments (Fogarty et al. 2017). 114 
Finally, methods have been developed allowing human embryos to transition from pre- to post-115 
implantation stages in vitro (Deglincerti et al. 2016; Shahbazi et al. 2016); these studies have 116 
shown GATA3 to be the most uniform marker of human TE, with CDX2 expressed less 117 
consistently among TE cells.  While all the above data point to numerous differences in 118 
mechanism(s) of TE fate specification in the human embryo, the exact sequence of events, 119 
including the transcriptional networks and signaling pathways involved, remain obscure. 120 
Even less is known about events surrounding implantation of the human embryo, which 121 
begins at ~7 days post-fertilization.  Studies by Hertig and Rock led to the first observations of 122 
this crucial period of development (Hertig et al. 1954; Hertig et al. 1956); however, most other 123 
knowledge of these events has arisen from in vitro culture of human embryos, performed, in 124 
large part, in context of fertility treatment.  Studies using human endometrial epithelial 125 
monolayers have shown that, in contrast to mouse embryos, the initial attachment of human 126 
embryos occurs via the polar TE, cells located adjacent to the inner cell mass (Lindenberg et al. 127 
1989). Subsequently, the embryo appears to dive underneath the endometrium, where, 128 
surrounded by endometrial stroma, the TE layer begins to expand and differentiate, giving rise to 129 
an inner layer of mononuclear cytotrophoblast (CTB) and an outer layer of primitive syncytium 130 
(Hertig et al. 1956; Boyd and Hamilton, 1970).  The latter cells are unusual in that, while 131 
multinucleated, they appear to be highly invasive, located at the forefront of the burrowing 132 
embryo; these cells should be distinguished from definitive syncytiotrophoblast, cells which arise 133 
slightly later in gestation, through cell-cell fusion of CTB.   134 
Within a few days following implantation, primary villi begin to form through 135 
invagination of the CTB layer; these are subsequently invaded by mesenchymal cells and 136 
eventually by fetal blood vessels, and undergo branching morphogenesis, leading to formation of 137 
mature chorionic villi, the functional units of the human placenta (Benirschke et al. 2012).  138 
Within the placental disc, floating chorionic villi, lined by an outer layer of multinucleated 139 
syncytiotrophoblast (STB), serve as the exchange interface for gases and nutrients.  At the basal 140 
plate (the maternal surface of the placental disc), anchoring villi attach to the uterine wall 141 
through trophoblast cell columns, structures composed of a progression of CTB differentiating 142 
into extravillous trophoblast (EVT) (Benirschke et al. 2012). Mature EVT are highly motile cells, 143 
which invade through the decidualized uterine stroma and up to the inner one-third of the 144 
myometrium, remodeling maternal spiral arterioles in order to optimally supply the fetoplacental 145 
unit with maternal blood (Benirschke et al. 2012). 146 
 147 
Traditional models for study of human trophoblast differentiation 148 
Placental explants can be generated from placental tissues of any gestation.  Although 149 
numerous culture conditions and uses have been described (reviewed by Miller et al. 2005), 150 
generally speaking, explants from first trimester placenta, cultured on collagen I, are often used 151 
for study of EVT differentiation and secretory/invasive functions (Knofler and Pollheimer, 152 
2013), while those from later gestation/term placenta, cultured on tissue culture inserts, are 153 
generally used to study STB function, including its secretion of various hormones and generation 154 
of extracellular vesicles (Fitzgerald et al. 2018; Tong and Chamley, 2018). Dual EVT/STB 155 
differentiation has also been achieved from first trimester placental explants, by first stripping of 156 
the STB layer to expose the underlying CTB, followed by culture under different oxygen 157 
tensions or growth factors to generate either EVT or STB (Caniggia et al. 2000; Baczyk et al. 158 
2006). However, the disadvantage of these models is the presence of a mixed cell type, which 159 
makes it difficult to assess or manipulate gene expression in a cell type-specific manner.  For this 160 
reason, researchers have turned to trophoblast isolation, specifically, isolation of CTB, the 161 
trophoblast progenitor cell type.  162 
Using the “Kliman” method (a series of enzymatic digests followed by Percoll gradient 163 
centrifugation), or variations thereof, CTB can be isolated which are relatively pure, and can be 164 
plated to generate either EVT/STB (from first trimester placenta) or STB alone (from later 165 
gestation/term placenta) (Kliman et al. 1986; Fisher et al. 1989).  Our own studies have pointed 166 
to oxygen tension, through hypoxia-inducible factor (HIF), regulating the switch between STB 167 
and EVT differentiation of first trimester CTB cultured on fibronectin (Wakeland et al. 2017). In 168 
addition, gene expression can be manipulated in purified CTB, as these cells are susceptible to 169 
transduction by lentivirus, at least within a few hours of plating (Chen et al. 2006; Wakeland et 170 
al. 2017). However, CTB isolations can be problematic, resulting in low or variable yields and 171 
purity, thus requiring additional steps (i.e. using magnetic-activated cell sorting or MACS for 172 
further purification) prior to use. Also, since they have a limited life span, at least by traditional 173 
culture methods, fresh cell isolates are needed for each new experiment, requiring continuous 174 
access to viable placental tissues, which can be difficult, particularly for early gestation tissues.  175 
For this reason, researchers have turned to established human trophoblast cell lines, of which 176 
multiple have been generated over the years.  177 
Trophoblast cell lines include those generated by immortalization, such as HTR8/SVneo 178 
and SW71 cell lines, generated by introduction of either the simian virus large T antigen or 179 
hTERT into first trimester trophoblast (Graham et al. 1993; Straszewski-Chavez et al. 2009).  180 
Other widely used trophoblast cell lines include BeWo and JEG3 cell lines, derived from 181 
gestational choriocarcinoma, a biphasic trophoblastic tumor (Cerneus and van der Ende 1991). 182 
However, these cells are suboptimal for studying trophoblast differentiation, as they can only 183 
mimic specific phenotypes of either EVT or STB, rather than be stimulated to differentiate from 184 
a progenitor to a terminally-differentiated phenotype.  In addition, while these cells are easy to 185 
culture and manipulate, and provide a much-needed starting point for evaluation of gene 186 
regulation and signaling pathways within the trophoblast compartment, they have abnormally 187 
amplified and/or aneuploid genomes, and there are significant gaps between their phenotypes 188 
and those of bona fide trophoblast cells in vivo (Apps et al. 2009; Bilban et al. 2010).  For these 189 
reasons, and in order to establish a consistent, widely-accessible model of human trophoblast 190 
differentiation starting with normal diploid cells, several groups have turned to use of pluripotent 191 
stem cells for study of trophoblast differentiation. 192 
 193 
Pluripotent stem cells as a model of human trophoblast differentiation 194 
The first derivation of human embryonic stem cell (hESC) lines from outgrowths of 195 
preimplantation human blastocysts was reported by Thomson’s group in 1998 (Thomson et al. 196 
1998). Shortly thereafter, Xu et al. (2002) reported that hESC can differentiate into hCG-197 
secreting multinucleated cell, resembling placental STB, using feeder conditioned media (FCM) 198 
supplemented with bone morphogenetic protein-4 (BMP4). An analogous observation was made 199 
when Gerami-Naini et al. reported secretion of hCG, estradiol, and progesterone from hESC-200 
derived embryoid bodies (EBs) grown in suspension then transferred onto Matrigel (Gerami-201 
Naini et al. 2004). Since then, multiple groups, including ours, have confirmed the ability of 202 
hESC, and later, that of induced pluripotent stem cells (iPSCs), into trophoblast, along the way 203 
making additional observations, further optimizing the protocol, but most importantly, defining 204 
the mechanisms underlying this process as it relates to early developmental events in the human 205 
embryo. 206 
One of the first mechanistic reports, confirming the involvement of the BMP receptor 207 
machinery, was published by Chen et al., showing that hESC lacking phosphatidyl-inositol-208 
glycan class A (PIG-A), required for the first step of glycosyl-phosphatidyl-inositol (GPI) 209 
synthesis, failed to induce trophoblast-associated genes, due to the lack of GPI-anchored BMP 210 
coreceptors (Chen et al. 2008). At about the same time, another group demonstrated that 211 
inhibition of Activin/Nodal signaling in hESC also induced the trophoblast lineage, although 212 
BMP signaling was still required for trophoblast differentiation in this context (Wu et al. 2008). 213 
While the initial focus was on the STB lineage derived from these cells, some groups 214 
soon began to also note the expression of EVT markers, such as HLA-G, first documented by 215 
Das et al. (2007).  Others compared BMP4-treated hESC against human mural TE, dissected 216 
from human embryos, finding significant overlap in gene expression:  one described a 217 
“trophectoderm core transcriptional regulatory circuitry” consisting of 13 transcription factors 218 
(including GATA2 and GATA3) that was recapitulated by the BMP4-treated hESC model (Bai 219 
et al. 2012); another study (Aghajanova et al. 2012) confirmed additional overlap between TE 220 
and BMP4-treated hESC in genes coding for TE-secreted proteins, including leukemia inhibitory 221 
factor (LIF), PSGs, inhibin, follistatin, and WNT, many of which are known to be involved in 222 
embryo implantation (Giudice 1999; Aghajanova 2004).  Both concluded, based on the above 223 
similarities in gene expression, that BMP4-treated hESC is at least a viable model for studying 224 
human trophoblast differentiation. 225 
Our group approached this model, asking the following question: if BMP4 induces 226 
terminally differentiated trophoblast lineages, including STB and EVT, does it do so through a 227 
developmentally correct program, i.e. through a CTB progenitor phase?  We answered this 228 
question by probing expression of TP63, a marker of epithelial stem cells which in the human 229 
placenta is uniquely expressed in CTB (Lee et al. 2007), in the context of BMP4-treated hESC.  230 
We found that TP63 is in fact induced prior to markers of more differentiated trophoblast, and 231 
that its knockdown prevented terminal trophoblast differentiation downstream of BMP4 (Li et al. 232 
2013). More recently, Krendl et al. identified steps involved in trophoblast lineage specification 233 
of hESC that are upstream of TP63, using a combination of transcriptome and epigenome 234 
profiling (Krendl et al. 2017).  They identified a combination of four transcription factors 235 
(GATA2, GATA3, TFAP2A, and TFAP2C), together called “TEtra,” which are expressed in 236 
human TE and regulate suppression of pluripotency and induction of trophoblast lineage-specific 237 
genes downstream of BMP4 (Krendl et al. 2017). 238 
Despite all the above evidence, the BMP4-based model of human trophoblast 239 
differentiation has remained under-utilized, most likely due to under-appreciation of the 240 
differences between mouse and human trophoblast, particularly during early gestation, as well as 241 
a lack of understanding of the role of BMP signaling in TE establishment and maintenance.  242 
Combined, these issues resulted in the conclusion that BMP4-treated hESC are, at best, 243 
extraembryonic mesoderm, not extraembryonic ectoderm (trophoblast) (Bernardo et al. 2011).  244 
But, in fact, this study used a suboptimal culture media for trophoblast differentiation of hESC, a 245 
media whose basal component was optimized for culture of mouse epiblast stem cells, and not 246 
hESC (The International Stem Cell Initiative Consortium, 2010). While the authors correctly 247 
pointed out that CDX2 is not trophoblast-specific, and as such, its induction should not be used 248 
exclusively to evaluate trophoblast differentiation of pluripotent stem cells, they otherwise relied 249 
on mouse placental studies for identification of trophoblast-specific markers.  In particular, they 250 
pointed to lack of induction of EOMES, a gene whose expression is completely lacking in both 251 
pre-implantation human TE and early post-implantation human trophoblast (Blakeley et al. 2015, 252 
Soncin et al. 2018), to reject the trophoblast identity of BMP4-treated hESC.  Finally, our gene 253 
expression profiling of human extraembryonic mesoderm (amnion and placental mesenchyme) 254 
and extraembryonic ectoderm/trophoblast (isolated primary CTB) has shown that BMP4-treated 255 
hESC cluster more closely with the latter (Li et al. 2013). 256 
With respect to the role of BMP signaling in embryonic patterning, it is true that, prior to 257 
the initial report of BMP4-based trophoblast differentiation of hESC (Xu et al. 2002), BMP4 258 
signaling had been mostly studied in the context of mesoderm induction (Zhao 2003). However, 259 
there have since been some clues that, in both mouse and human, this pathway is not exclusive to 260 
mesoderm induction:  specifically, mouse embryos lacking Bmpr1a show not just lack of 261 
Brachyury/T (a gene required for early mesoderm differentiation) expression within the embryo-262 
proper, but are also missing Eomes (a gene required for trophoblast stem cell maintenance in the 263 
mouse) expression from the extraembryonic ectoderm (Di-Gregorio et al. 2007). More recently, 264 
single cell RNAseq of human blastocysts has confirmed expression of multiple components of 265 
the TGFb/BMP signaling pathway in this early stage of development, with several components 266 
(including SMAD1 and SMAD5) more highly expressed within human TE (Blakely et al. 2015), 267 
indicating that, at the very least, these cells express the machinery required to respond to BMP 268 
signaling. 269 
In fact, the balance of mesoderm and trophoblast differentiation downstream of BMP4 270 
treatment of hESC has been documented in several studies.  Yu et al. (2011) evaluated the role of 271 
FGF signaling, which, in the presence of BMP4, was found to sustain expression of NANOG, 272 
leading to induction of BRACHYURY/T, a mesoderm marker.  Amita et al. (2013) used this 273 
information to establish more optimized conditions for trophoblast differentiation of hESC, 274 
applying a combination of BMP4, A83–01 (a TGF𝛽 inhibitor), and PD173074 (an FGF receptor 275 
inhibitor).  Termed “BAP,” this protocol inhibits mesoderm induction and accelerates 276 
trophoblast differentiation of hESC, compared to BMP4 alone, rapidly producing terminally-277 
differentiated STB and EVT (Amita et al. 2013). A more recent study has better delineated the 278 
mechanism of BMP4-mediated mesoderm vs. trophoblast differentiation.  Using both hESC and 279 
mouse epiblast stem cells (mEpiSCs), Kurek et al. (2015) showed that BMP4-mediated 280 
mesoderm induction, but not trophoblast induction, of these cells is WNT-dependent; thus, 281 
inhibitors of WNT signaling can be used to drive differentiation exclusively into the trophoblast 282 
lineage. We have used this information to establish an optimized protocol for BMP4-mediated 283 
trophoblast differentiation of pluripotent stem cells, using a combination of BMP4 and IWP2 to 284 
establish a pure population of CTB progenitor cells (Horii et al. 2019). Note that the need for 285 
WNT inhibition is specific to the transition from pluripotency to the trophoblast lineage; this is 286 
distinct from the need for WNT activation in maintenance of the trophoblast stem cell state (see 287 
“New models of human trophoblast differentiation: Human trophoblast stem cells” below). 288 
As a model for normal human trophoblast differentiation, pluripotent stem cells (hPSCs) 289 
can be useful because they are widely available, and, particularly with the establishment of 290 
reprogramming methods for derivation of induced pluripotent stem cells (iPSC) from a variety of 291 
human somatic cells (Takahashi et al. 2007), a more widely-acceptable system.  Given the 292 
pluripotent state of the starting material, this model system allows for the study of, not just 293 
human trophoblast differentiation, but also, of human trophoblast lineage specification.  In fact, 294 
this model system has been used for this purpose, as described above, establishing a role for the 295 
“TEtra” factors (GATA2, GATA3, TFAP2A, TFAP2C) in suppression of pluripotency and 296 
induction of the trophoblast lineage (Krendl et al. 2017).  It has also been used to show that, 297 
similar to mouse, the TEA domain protein TEAD4 may be involved in human trophoblast 298 
lineage specification, by induction of GATA3 expression, downstream of BMP4 signaling 299 
(Home et al. 2012).  In our own studies, we have developed a two-step protocol, which separates 300 
trophoblast lineage specification from terminal trophoblast differentiation (Horii et al. 2016; 301 
Horii et al. 2019).  In the first step, we use a combination of BMP4 and IWP2 in a minimal basal 302 
media, to derive formation of a pure population of EGFR+ CTB progenitor cells (Horii et al. 303 
2019).  These cells are subsequently replated for terminal differentiation (into STB and EVT), 304 
using BMP4 in the setting of feeder-conditioned media (FCM) (Horii et al. 2016, Horii et al. 305 
2019).  We have used this system to show a possible role for VGLL1, a transcriptional co-factor, 306 
in induction of TP63 and human trophoblast lineage specification (Soncin et al. 2018). 307 
But perhaps the most compelling reason to use BMP4-treated hPSCs is for modeling 308 
terminal trophoblast differentiation, particularly into EVT, but also into STB, in the setting of 309 
both normal development and placenta-based pregnancy disorders, such as recurrent miscarriage, 310 
preeclampsia, and fetal growth restriction.  Since CTB isolated from term placentae cannot 311 
differentiate into EVT (McMaster et al. 1995), the study of this lineage is limited to use of 312 
human trophoblast cell lines (i.e. HTR8-SVneo) or CTB isolated from first trimester human 313 
placental tissues.  Since the latter are primarily sourced from elective terminations of pregnancy, 314 
their use may be limited due to both lack of knowledge about their disease potential (unknown 315 
pregnancy outcome) as well as local, state, or federal laws in some jurisdictions. We have shown 316 
that hPSC-derived CTB can be preferentially differentiated into HLA-G+, MMP2-secreting, 317 
invasive EVT using FCM+BMP4 under low oxygen tension (2%) (Horii et al. 2016).  We know 318 
that these cells reflect the same process in first trimester placenta, since both CTB derived from 319 
these tissues and hPSC-derived CTB differentiate into EVT under low oxygen tension in a HIF-320 
dependent manner (Horii et al. 2016; Wakeland et al. 2017).  321 
Our work has also established proof-of-concept for use of BMP4-treated hPSCs for 322 
modeling abnormal trophoblast differentiation.  Using hPSCs which harbor an extra chromosome 323 
21, we have shown that STB differentiation is compromised in this setting, similar to STB 324 
differentiation of primary CTB derived from Trisomy 21-involved placentae (Horii et al. 2016).  325 
Both primary and hPSC-derived CTB with Trisomy 21 showed defects in cell-cell fusion which 326 
could be rescued by activin treatment (Horii et al. 2016). Most recently, Sheridan et al (2019) 327 
have established iPSCs from a cohort of normal and preeclamptic (PE) pregnancies and, using 328 
the “BAP” protocol for trophoblast differentiation of these cells, have shown that PE-iPSC-329 
derived trophoblast display a defect in invasion under high oxygen (20%) tension. Although they 330 
have yet to characterize where the defect(s) occur(s) within the PE-iPSC-derived trophoblast, the 331 
fact that the phenotype of a complex pregnancy disorder can be recapitulated using this model 332 
system is extremely novel and exciting. 333 
Nevertheless, hPSCs as a model for human trophoblast differentiation have several 334 
limitations.  Most importantly, even though many human TE- and trophoblast-associated genes 335 
are induced in this system, BMP4-treated hPSCs do not fully resemble primary trophoblast based 336 
on marker expression (Aghajanova et al. 2012; Li et al. 2013).  One glaring difference is the 337 
absent-to-low expression of ELF5, a transcription factor required for mouse trophoblast stem cell 338 
lineage specification and maintenance, which is also expressed at high levels in trophoblast of 339 
the early gestation human placenta (Hemberger et al. 2010).  At least in mouse, Elf5 expression 340 
is regulated by promoter methylation, with high methylation levels (and hence absent 341 
expression) in mouse ESC and low levels (and hence expression of the gene) in mouse TSC (Ng 342 
et al. 2008).  Human first trimester placental tissues also show hypomethylation of the ELF5 343 
promoter, with ELF5 expressed in villous CTB (Hemberger et al. 2010).  Human ESCs, on the 344 
other hand, show hypermethylation of the ELF5 promoter, even after treatment with BMP4 345 
(Hemberger et al. 2010), although BMP4 treatment does decrease this methylation (Sarkar et al. 346 
2015).  Nevertheless, it is not clear whether, in this setting, this is a limitation of the BMP4-347 
based model, or whether this gene is simply not required for trophoblast lineage specification in 348 
human.  The latter may be a possibility as, unlike mouse, ELF5 is not expressed in the TE of 349 
preimplantation human embryos (Blakeley et al. 2015), with its expression delayed until early 350 
post-implantation human trophoblast (Soncin et al. 2018).  A second limitation is the continued 351 
expression of HLA class I antigens (Bernardo et al. 2011); however, it is noteworthy that the 352 
expression of these antigens does decrease following BMP4-induced trophoblast differentiation 353 
of pluripotent stem cells (Sarkar et al. 2015).  Other limitations of the BMP4-based hPSC model 354 
include the as-yet undefined conditions for lineage-specific differentiation into EVT or STB, and 355 
the lack of mature markers within either trophoblast subpopulation, indicating that further 356 
optimization of terminal trophoblast differentiation is necessary (Yabe et al. 2016; Horii et al. 357 
2019).  For this reason, comparison to primary cells continues to be required to improve and 358 
validate this system for further use. 359 
 360 
New models of human trophoblast differentiation: Human trophoblast stem cells  361 
Over two decades ago, mouse trophoblast stem cells (mTSCs) were first derived from 362 
either pre-implantation blastocyst-stage or extraembryonic ectoderm of early post-implantation 363 
embryos, using a combination of fibroblast growth factor-4 (FGF4) and media conditioned by 364 
mouse embryonic fibroblasts (MEF-CM) (Tanaka et al. 1998). Further studies showed that a 365 
combination of FGF4 and TGFb/Activin signaling contributes to maintenance of these cells in 366 
their undifferentiated, stem-like state, and that their removal leads to differentiation into both 367 
labyrinthine and spongiotrophoblast/trophoblast giant cell lineages, cells equivalent to human 368 
villous and extravillous trophoblast (Tanaka et al. 1998; Erlebacher et al. 2004; Soncin et al. 369 
2015). Since this discovery, mTSCs have been used to study the role of multiple genes and 370 
signaling pathways important for trophoblast differentiation and placental development (Rossant 371 
2001; Yagi et al. 2007; Senner and Hemberger. 2010; Home et al. 2017). However, despite many 372 
attempts, the same conditions could not be applied to human embryos for derivation of 373 
analogous cells, likely due to differences in early developmental stages of mouse and human 374 
embryos (Niakan and Eggan. 2013; Kunath et al. 2014; Blakeley et al. 2015). Recently, Okae et 375 
al. (2018) applied knowledge of culture conditions for propagation and maintenance of epithelial 376 
stem cells to derive human trophoblast stem cells (hTSCs) from both blastocyst-stage human 377 
embryos and early first trimester placentae. These hTSCs use a combination of WNT activation 378 
and TGFb inhibition to self-renew, and can be maintained in culture long-term, and be cryo-379 
preserved for the later usage. They express numerous markers of early gestation trophoblast, 380 
including TEAD4, GATA3, TP63, as well as ELF5, and can differentiate into both STB and 381 
EVT (Okae et al. 2018). 382 
While the derivation of these cells is a significant advance for the field of placental 383 
biology, several questions remain with respect to these cells.  First, similar to primary cells from 384 
these tissue sources, these cells may remain of limited value due to the ethical and legal 385 
challenges against their use and their unknown disease potential.  Second, while their profile 386 
(including expression of ITGA6) suggests that they originate from CTB, their exact location 387 
within the placenta remains unknown.  The fact that they could not be derived from later 388 
gestation placental tissues may suggest the presence of a specific niche within the first trimester 389 
placenta; alternatively, it is possible that TSCs exist in later gestation but in significantly reduced 390 
numbers.  Several groups have recently analyzed cellular heterogeneity within both the first 391 
trimester and term placentae using single-cell RNAseq (Pavlicev et al. 2017; Tsang et al. 2017; 392 
Vento-Tormo et al. 2018; Suryawanshi et al. 2018; Liu et al. 2018).  Analyses of these data, 393 
particularly comparing the CTB cell types at different gestational ages, may shed light on 394 
whether the TSC niche is in fact unique to early gestation and determine if this niche can be 395 
maintained later into pregnancy.  Such a discovery could advance our understanding of placental 396 
regeneration, potentially laying the groundwork for targeting of this organ for regenerative 397 
therapy. 398 
 399 
New models of human trophoblast differentiation: 3D models of the human placenta 400 
While 2D culture is convenient and has been the standard for many years, 3D tissue 401 
culture offers conditions that are more physiologically relevant to the in vivo environment.  Over 402 
the past few years, there have been rapid advances in 3D culture systems, with the development 403 
of miniature organs or “organoids,” as well as establishment of “organs-on-a-chip” (Huh et al. 404 
2011).  These advances have recently reached the human placenta field, with multiple groups 405 
establishing such model systems.   406 
Specifically, two groups have generated self-replicating trophoblast organoids from first 407 
trimester placental tissues (Haider et al. 2018; Turco et al. 2018). Both groups used media with 408 
similar composition to that used for hTSCs (Okae et al. 2018), resulting in organoids which hold 409 
similar structures, with an outer CTB layer and inner group of STB (Haider et al. 2018; Turco et 410 
al. 2018). There were slight differences in passaging and choice of differentiation media. 411 
Specifically, Turco et al. chose an EVT differentiation media which is most similar to that used 412 
by Okae et al. (2018), containing neuregulin-1 (NRG1) as the initiating factor (Turco et al. 413 
2018); at the same time, Haider et al. showed that removal of WNT activators (R-spondin and 414 
CHIR99021) from their organoid media was sufficient to initiate differentiation into NOTCH1+ 415 
EVT precursors, while WNT signaling was required for further differentiation of EVT (Haider et 416 
al. 2018). Similar to hTSCs, trophoblast organoids have only been derived from first trimester 417 
placental tissues, again rendering these models of potential limited value due to the ethical and 418 
legal challenges to their use and their unknown disease potential, thus necessitating further 419 
studies for establishment of similar organoids from later gestation tissues.  Another potential 420 
limitation of these organoids is that their morphology contrasts with that of chorionic villi, with 421 
CTB comprising the outer layer and STB being confined to the inner compartment (Haider et al. 422 
2018; Turco et al. 2018).  This results in the presence of a mixed group of trophoblast in culture, 423 
which may confound data analysis; at the same time, the simultaneous presence of different 424 
lineages may allow (through cross-talk) better maintenance and/or differentiation of the distinct 425 
cell types. In addition, differentiation of the outer CTB into EVT may better recapitulate the 426 
trophoblast cell column, allowing the study of progressive differentiation of cells into this 427 
lineage (Haider et al. 2018). 428 
 Aside from organoids, several other methods of 3D culture have recently been developed 429 
to study trophoblast function, mostly in context of the chorionic villus, the main exchange 430 
interface of the human placenta.  McConkey et al. (2016) used the rotating wall vessel bioreactor 431 
to culture JEG3 attached to Cytodex beads, resulting in formation of multinucleated (STB-like) 432 
cells which, similar to primary term STB, were resistant to infection by viruses as well as 433 
Toxoplasma gondii.  More recently, multiple groups have developed “placenta-on-a-chip” 434 
models of chorionic villus in order to mimic the transport functions of the placenta in vitro 435 
(Blundell et al. 2016; Arumugasaamy et al. 2018; Nishiguchi et al. 2019).  These models offer an 436 
advantage over both 2D models and 3D organoid culture, providing a platform for studying 437 
transport of drugs, nutrients, and pathogens across the vasculosyncytial barrier.  They can also be 438 
modified to model the barrier at different gestational ages and manipulated, both genetically and 439 
environmentally, to reproduce disease-like conditions.  However, most of these studies so far 440 
have used BeWo (choriocarcinoma-derived) cells for modeling the trophoblast barrier, with only 441 
one group (Nishiguchi et al. 2019) using primary CTB.  Nevertheless, these novel technologies 442 
provide a platform for studying transport across the villus barrier, a process which is otherwise 443 
difficult to study, relying mostly on ex vivo perfusion of human placenta after delivery.  444 
Development of these novel 3D systems will allow the study of cell-cell communications and 445 
their effect on placental function significantly advancing our understanding of structure-function 446 
relationships within this organ. 447 
 448 
Conclusions and Future Perspectives 449 
The human placenta is a difficult organ to study, in part due to lack of a proper model 450 
system for its main functional epithelial component, the trophoblast. This review has focused on 451 
describing advances in regenerative medicine-based technologies, including derivation of human 452 
embryonic and, more recently, trophoblast stem cells, from blastocyst-stage human embryos 453 
(Figure 1A), derivation of trophoblast stem cells and trophoblast organoids from early gestation 454 
human placenta (Figure 1B), and derivation of induced pluripotent stem cells and establishment 455 
of methods for their differentiation toward the trophoblast lineage (Figure 1C).  We will now 456 
touch on some of the most important possible next steps. 457 
One of the most exciting advances discussed in this review is the ability to reprogram 458 
cells of a placenta at delivery, for which the pregnancy outcome is known, generating iPSCs 459 
which can then be differentiated into trophoblast (see Figure 1C).  Currently, this has only been 460 
done with mesenchymal stem cells (MSCs) from normal and preeclamptic placentae, with 461 
trophoblast differentiation of the resulting iPSCs showing phenotypic abnormalities that correlate 462 
with this placental dysfunction (Sheridan et al. 2019).  However, much work remains to be done, 463 
including more optimal differentiation of iPSCs into trophoblast and establishment of iPSC for 464 
modeling other placental disorders.  One possibility is to use the media and culture techniques 465 
recently developed for hTSC and trophoblast organoids and apply them to iPSC-derived CTB in 466 
order to establish iPSC-derived “TSC” (see Figure 1C).  One group claims to have applied the 467 
Okae et al. (2018) media to hESC-derived trophoblast with resulting cells which resemble 468 
primary hTSC based on their transcriptome (Mischler et al. 2019).  Another more recent 469 
publication first converts hESC/iPSC first into a “naïve” state of pluripotency, then applies the 470 
media established by Okae et al. (2018) to derive TSC-like cells (Dong et al. 2020). However, 471 
what is not clear is whether this latter method would preserve the disease-specific epigenetic 472 
marks on iPSC.  Additional studies, particularly comparison of TSC derived from both naïve vs. 473 
primed hESC/iPSC, is needed to address this question. 474 
Perhaps a more optimal method for derivation of disease-specific iPSC would be to start 475 
by using primary term CTB, instead of MSCs, from diseased placentae, potentially leading to an 476 
epigenetic state in the resulting iPSC-derived TSC that is more representative of the cell-of-477 
origin (trophoblast) that we aim to study (see Figure 1C).  Finally, another exciting possibility 478 
would be to apply our knowledge of transcription factors that induce human trophoblast lineage 479 
and hTSC maintenance to CTB and/or MSC, and reprogram these cells directly into TSC (i.e. 480 
generate “induced trophoblast stem cells” or iTSCs, Figure 1C), rather than going through a 481 
pluripotent intermediate.  This has already been done in mouse, generating iTSC that mimic 482 
primary, blastocyst-derived TSC (Kubaczka et al. 2015; Benchetrit et al. 2015).   483 
Just as the Okae media have been applied to hESC/iPSC, so can the culture methods for 484 
derivation of trophoblast organoids.  Since hESC/iPSC can also be genetically manipulated, the 485 
role of specific genes can be tested in both maintenance and differentiation of TSC derived from 486 
these cells.  In addition, both primary and hESC/iPSC-derived hTSC can theoretically be 487 
combined with organ-on-a-chip technologies, in order to model the vasculosyncytial barrier with 488 
both normal and abnormal trophoblast. This, combined with the ability to genetically manipulate 489 
the component cell types, will allow for modeling of the human placenta, not just during normal 490 
development but also in numerous pregnancy-associated disorders, establishing models that can 491 
be used for identification of both diagnostic markers and therapeutic targets. 492 
The development of the above technologies has allowed for establishment of significantly 493 
more advanced models of human trophoblast.  However, much work still remains, particularly in 494 
the actual application of these systems for better understanding human placental function and 495 
modeling placenta-based pregnancy complications. 496 
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Figure Legend 855 
 856 
Figure 1. A) An illustration of a blastocyst-stage human embryo. Both human embryonic stem 857 
cells (ESC) and trophoblast stem cells (TSC) have now been established, derived from the inner 858 
cell mass (ICM) and trophectoderm (TE) of human embryos. B) An illustration of early gestation 859 
(first trimester) human placenta.  While primary cytotrophoblast (CTB) derived from this tissue 860 
have been the gold standard in studies of human trophoblast differentiation for many years, 861 
recent studies have established protocols for derivation of trophoblast stem cells (TSC) and 862 
trophoblast organoids, which can self-replicate and be further differentiated into both 863 
syncytiotrophoblast and extravillous trophoblast.  Utility of both embryo- and first trimester 864 
placenta-derived cells is limited by ethical issues as well as their unknown disease potential. C) 865 
An illustration of human placenta at delivery.  Current reprogramming technologies enable us to 866 
generate induced pluripotent stem cells (iPSCs) starting with somatic cell types, including 867 
placental cells at delivery.  This has been done mostly using mesenchymal stem cells (MSCs) 868 
derived from the umbilical cord, but can also potentially be done using cytotrophoblast (CTB) as 869 
starting material.  iPSCs (as well as ESC) can be differentiated into trophoblast using various 870 
protocols.  Application of TSC/organoid culture media to iPSC/ESC-derived trophoblast has the 871 
potential to generate TSC-like cells. At the same time, TSC-specific 872 
transcription/reprogramming factors could potentially be used to generate “induced trophoblast 873 
stem cells” (iTSC), directly from MSCs or CTBs.  This model system is potentially powerful, 874 
because it will be applicable not only to normal pregnancies but also to pregnancies associated 875 
with placenta-based dysfunction.  Note that the blue arrow indicates a method which has already 876 
been established and applied, the green arrow represents technology that is available but has yet 877 
to be applied, and the red arrow points to protocol(s) that have yet to be developed. 878 
 879 

Table 1:  List of abbreviations 
 
Abbreviation Definition 
BAP Combination of BMP4, A83–01, and PD173074 
BMP4 Bone morphogenetic protein-4 
CTB Cytotrophoblast 
EB Embryoid bodies 
EpiSC Epiblast stem cells 
ESC Embryonic stem cells 
EVT Extravillous trophoblast 
FGF4 Fibroblast growth factor-4 
GPI Glycosyl-phosphatidyl-inositol 
hCG Human chorionic gonadotropin 
HIF Hypoxia-inducible factor 
HLA Human leukocyte antigen 
hPL Human placental lactogen 
hPSC Human pluripotent stem cells (includes iPSC and hESC) 
ICM Inner cell mass 
iPSC Induced pluripotent stem cells 
iTSC Induced trophoblast stem cells 
LIF Leukemia inhibitory factor 
MACS Magnetic-activated cell sorting 
MEF Mouse embryonic fibroblast/feeders 
MEF-CM Mouse embryonic fibroblast/feeder-conditioned media 
MSC Mesenchymal stem cells 
PSG Pregnancy-specific glycoprotein 
STB Syncytiotrophoblast 
TE Trophectoderm 
TGFb Transforming growth factor beta 
TSC Trophoblast stem cells 
 
 
